2 weeks Emergent Biosolutions (EBS) Q4 Earnings Top Estimates Zacks

Emergent Biosolutions (EBS) delivered earnings and revenue surprises of 114.29% and 22.93%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?